Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP655224.RAigU7grTQWsFAyRxiSb4i6NMORpo2qYkLJe-dxXUZyFA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP655224.RAigU7grTQWsFAyRxiSb4i6NMORpo2qYkLJe-dxXUZyFA130_assertion type Assertion NP655224.RAigU7grTQWsFAyRxiSb4i6NMORpo2qYkLJe-dxXUZyFA130_head.
- NP655224.RAigU7grTQWsFAyRxiSb4i6NMORpo2qYkLJe-dxXUZyFA130_assertion description "[The decreased tumor burden was associated with decreased bone resorption (serum TRAP5b levels were decreased by 50-60% in anti-CCL2-treated animals from VCaP or PC-3 cell osseous lesions) and microvessel density was decreased by 70% in anti-CCL2-treated animals with bone lesions from VCaP cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655224.RAigU7grTQWsFAyRxiSb4i6NMORpo2qYkLJe-dxXUZyFA130_provenance.
- NP655224.RAigU7grTQWsFAyRxiSb4i6NMORpo2qYkLJe-dxXUZyFA130_assertion evidence source_evidence_literature NP655224.RAigU7grTQWsFAyRxiSb4i6NMORpo2qYkLJe-dxXUZyFA130_provenance.
- NP655224.RAigU7grTQWsFAyRxiSb4i6NMORpo2qYkLJe-dxXUZyFA130_assertion SIO_000772 19176388 NP655224.RAigU7grTQWsFAyRxiSb4i6NMORpo2qYkLJe-dxXUZyFA130_provenance.
- NP655224.RAigU7grTQWsFAyRxiSb4i6NMORpo2qYkLJe-dxXUZyFA130_assertion wasDerivedFrom befree-20140225 NP655224.RAigU7grTQWsFAyRxiSb4i6NMORpo2qYkLJe-dxXUZyFA130_provenance.
- NP655224.RAigU7grTQWsFAyRxiSb4i6NMORpo2qYkLJe-dxXUZyFA130_assertion wasGeneratedBy ECO_0000203 NP655224.RAigU7grTQWsFAyRxiSb4i6NMORpo2qYkLJe-dxXUZyFA130_provenance.